Artivion Inc (AORT) is a Healthcare · Medical Devices company listed on NYSE. Price $23.87 (-0.04%), Market cap $1.11B, P/E ratio 91.08, 52-week low–high $22.23 ~ $47.63.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular dise
Financial statements, price targets, institutional (13F) holdings and related news for Artivion Inc are updated in real time on BlackAll Trade.
Artivion Inc trades at $23.87 (-0.04%). Real-time quotes and charts are available on BlackAll Trade.
Artivion Inc has a market cap of about $1.11B. Its P/E ratio is 91.08.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aorti